Events

CHI 2014 Annual Meeting

Stanford University

2014-CHI-AM-logo-with-titleDate: November 20, 2014
Time:
9:30 a.m.- 5:00 p.m.
Location:
 Paul Berg Hall, Li Ka Shing Center, Second Floor, Stanford University, 291 Campus Drive West, Palo Alto, CA
Parking Directions

Our healthcare system is in the midst of significant change, with reforms – accelerated by but predating the Affordable Care Act – that will greatly affect all stakeholders, including developers of new medicines and technologies. Along with these changes comes uncertainty and numerous challenges, but also great opportunity. CHI’s 2014 Annual Meeting will convene key opinion leaders from across the healthcare stakeholder community to discuss what these trends mean, what policy decisions in Washington, Sacramento and the private sector are driving them, and the role of California’s innovative biomedical research and development sector as a key solution to providing patients and the broader healthcare system with true value.

CHI ANNL MTG-144 WEB ONLY 72dpiCHI ANNL MTG-071 WEB ONLY 72dpiCHI ANNL MTG-025 WEB ONLY 72dpi
Speakers:

Welcome and The Role of Academic Medicine in a Transforming Healthcare Environment

  • Lloyd B. Minor, M.D., Dean, Stanford University School of Medicine

The Promise of Digital Health to Revolutionize Patient Care

  • Introduction by Christian Nolet, Partner & Life Sciences Industry Leader, Ernst & Young
  • Andrew M. Thompson, Co-Founder & CEO, Proteus Digital Health

The Value of Innovation on Patient Care

  • Clive Svendsen, Ph.D., Director of Regenerative Medicine Institute, Cedars-Sinai

Leveraging Basic Research Into Therapies and Cures

  • Moderator: Kenneth E. Drazan, M.D., Head, Johnson & Johnson Innovation Centers in California
  • Steven T. Rosen, M.D., Provost/Chief Scientific Officer, City of Hope
  • Andrew J. Schwab, Founder & Managing Partner, 5AM Ventures
  • Paul G. Yock, M.D., Director, Stanford Biodesign

Crystal Ball: A Look at Future Innovations

  • Mitchell Spearrin, Ph.D., Postdoctoral Fellow, Stanford University
  • Kate Rosenbluth, Ph.D., CEO, Cala Health
  • Julie Saiki, SPARK Graduate Student, Stanford University

Biomedical Industry Report Launch Luncheon

  • Peter Claude, Partner, PwC
  • Todd Gillenwater, President & CEO, California Healthcare Institute

“Value-Driven” Health Care: What is the Role of Biomedical Innovation?

  • Introduction by Dana Goldman, Ph.D., Professor and the Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy and Economics
  • Moderator: Joshua J. Ofman, M.D., M.S.H.S., SVP, Global Value, Access & Policy, Amgen
  • David Lansky, Ph.D., President & CEO, Pacific Business Group on Health
  • Lewis G. Sandy, M.D., F.A.C.P., Executive Vice President, Clinical Advancement

Networking Break

  • State Senator Jerry Hill, 13th District
  • State Assemblymember Rich Gordon, 24th District

The Patient Perspective 

  • Manny Hernandez, Co-Founder & President, Diabetes Hands Foundation

The Next Frontier: Life Sciences Convergence with Silicon Valley

  • Moderator: Deborah Marshall, Partner, Sidley Austin
  • Leslie Bottorff, Managing Director, Healthcare, GE Ventures
  • Jason Oberfest, Co-Founder & CEO, Mango Health
  • Afia Asamoah, Product Counsel, Google

Closing Remarks and Reception 

  • Rick Winningham, Chairman & CEO, Theravance Biopharma

 

Time Panel Topic
9:30 – 10:00 a.m. Registration & Networking
10:00 – 10:20 a.m. Welcome & The Role of Academic Medicine in a Transforming Healthcare Environment

  • Lloyd B. Minor, M.D., Dean, Stanford University School of Medicine
10:20 – 10:45 a.m. The Promise of Digital Health to Revolutionize Patient Care

  • Introduction by Christian Nolet, Partner & Life Sciences Industry Leader, Ernst & Young
  • Andrew M. Thompson, Co-Founder & CEO, Proteus Digital Health
10:45 – 11:00 a.m. The Value of Innovation on Patient Care

  • Clive Svendsen, Ph.D., Director of Regenerative Medicine Institute, Cedars-Sinai
11:00 – 11:45 a.m. Leveraging Basic Research Into Therapies and CuresThis panel will focus on the critical role of California’s public and private research universities and institutes in fueling advances in cutting-edge sciences and technologies that are the bedrock of our state’s biomedical innovation ecosystem, and which extend far beyond the lab and into the clinic and direct patient care.

  • Moderator: Kenneth E. Drazan, M.D., Head, Johnson & Johnson Innovation Centers in California
  • Steven T. Rosen, M.D., Provost/Chief Scientific Officer, City of Hope
  • Andrew J. Schwab, Founder & Managing Partner, 5AM Ventures
  • Paul G. Yock, M.D., Director, Stanford Biodesign
11:45 a.m. – 12:00 p.m. Crystal Ball: A Look at Future Innovations

  • Mitchell Spearrin, Ph.D., Postdoctoral Fellow, Stanford University
  • Kate Rosenbluth, Ph.D., CEO, Cala Health
  • Julie Saiki, SPARK Graduate Student, Stanford University
12:00 p.m. – 1:15 p.m. Biomedical Industry Report Launch Luncheon

  • Peter Claude, Partner, PwC
  • Todd Gillenwater, President & CEO, California Healthcare Institute
1:15 – 1:30 p.m. Introducing Value-Driven Health Care: What is the Role of Biomedical Innovation?

  • Dana Goldman, Ph.D., Professor and the Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy and Economics
1:30 – 2:15 pm. “Value-Driven” Health Care: What is the Role of Biomedical Innovation?Our healthcare system is in the midst of significant change, with reforms – accelerated by but predating the Affordable Care Act – that will greatly affect all stakeholders, including developers of new medicines and technologies. This panel will explore the ongoing trend towards “value based” payment and delivery mechanisms, and the important dialogue that must continue between payers, providers, purchasers and innovators to ensure a truly patient-centered healthcare system.

  • Introduction by Dana Goldman, Ph.D., Professor and the Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy and Economics
  • Moderator: Joshua J. Ofman, M.D., M.S.H.S., SVP, Global Value, Access & Policy, Amgen
  • David Lansky, Ph.D., President & CEO, Pacific Business Group on Health
  • Lewis G. Sandy, M.D., F.A.C.P., Executive Vice President, Clinical Advancement
2:15 – 2:45 p.m. Networking Break

  • State Senator Jerry Hill, 13th District
  • State Assemblymember Rich Gordon, 24th District
2:45 – 3:00 p.m. The Patient Perspective 

  • Manny Hernandez, Co-Founder & President, Diabetes Hands Foundation
3:00 – 3:45 p.m. The Next Frontier: Life Sciences Convergence with Silicon Valley
California is the epicenter of an exciting convergence between traditional life sciences and Silicon Valley. This convergence promises numerous opportunities for improvements in public and patient health – if we have the right regulatory and payment policies put in place in Washington, Sacramento and the private market.

  • Moderator: Deborah Marshall, Partner, Sidley Austin
  • Leslie Bottorff, Managing Director, Healthcare, GE Ventures
  • Jason Oberfest, Co-Founder & CEO, Mango Health
  • Afia Asamoah, Product Counsel, Google
3:45 – 5:00 p.m. Closing remarks and reception

  • Rick Winningham, Chairman & CEO, Theravance Biopharma
Welcome and The Role of Academic Medicine in a Transforming Healthcare Environment

minor

Lloyd B. Minor, M.D. Dean, Stanford University School of Medicine

Lloyd B. Minor, MD is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, a position he has held since December 1, 2012. He is also a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.

The Promise of Digital Health to Revolutionize Patient Care

nolet

Christian Nolet, Partner & Life Sciences Industry Leader, Ernst & Young

Chris Nolet is a partner with Ernst & Young in Palo Alto, California. Nolet joined Ernst & Young in 2001 after more than 21 years with PricewaterhouseCoopers, where he was a Partner and Leader – North America West Life Sciences Industry Group. With Ernst & Young, Nolet serves a number of the firm’s premier clients, including Genentech and Affymetrix. In addition, he supports E&Y engagement teams and health sciences clients throughout California and the western United States

thompsonAndrew M. Thompson Co-Founder & CEO, Proteus Digital Health
Andrew Thompson is President, Chief Executive Officer and co-founder of Proteus Digital Health, and has led the company since its inception. A veteran of Silicon Valley bio-medical startups, he was President, Chief Executive Officer and co-founder of FemRx (NASDAQ IPO, acquired by JNJ) and Chief Financial Officer of CardioRhythm (acquired by Medtronic).

The Value of Innovation on Patient Care

CliveClive Svendsen, Ph.D., Director of Regenerative Medicine Institute, Cedars-Sinai

Clive N. Svendsen, joint leader of the widely-respected Stem Cell and Regenerative Medicine Center at the University of Wisconsin, was named the director of the Cedars- Sinai Regenerative Medicine Institute in December 2009.Under Svendsen’s direction, the Cedars-Sinai Regenerative Medicine Institute brings together basic scientists with specialist clinicians, physician scientists and translational scientists across multiple medical specialties to translate fundamental stem cell studies to therapeutic regenerative medicine.

Leveraging Basic Research Into Therapies and Cures

drazan

Kenneth E. Drazan, M.D. (Moderator) Head, Johnson & Johnson Innovation Centers in California

Ken is Head of Johnson & Johnson Innovation, California. His background includes more than 13 years in the healthcare industry and 12 years in the hospital and academic worlds. A liver transplant surgeon by training, Ken spent several years at Stanford University before moving into entrepreneurial leadership roles in the biopharmaceutical industry and subsequently in the venture capital world. Ken’s deep background in science, his business experience, and his strong ties to the Bay Area life science community provide a unique combination of skills and expertise to his leadership.

yock

Paul G. Yock, M.D. Director, Stanford Biodesign

Paul Yock is the Martha Meier Weiland Professor of Medicine and Mechanical Engineering (by courtesy) and Founding Co-Chair of Stanford’s new Department of Bioengineering. He also holds a courtesy appointment on Operations, Information and Technology in the Stanford School of Business.

Rosen

Steven T. Rosen, M.D. Provost/Chief Scientific Officer, City of Hope

Steven T. Rosen, M.D., is provost and chief scientific officer for City of Hope and a member of City of Hope’s Executive Team. He also is director of the Comprehensive Cancer Center and holds the Irell & Manella Cancer Center Director’s Distinguished Chair, and he is responsible for Beckman Research Institute and the Irell & Manella Graduate School of Biological Sciences.

Schwab

Andrew J. Schwab, Founder & Managing Partner, 5AM Ventures

Andrew J. Schwab is a Founder and Managing Partner of 5AM Ventures. Prior to founding 5AM in 2002, Mr. Schwab was a Principal at Bay City Capital. After joining Bay City Capital in 1999, he led the firm’s investment and merchant banking activities for such companies as Cubist, Metabolex, PTC Therapeutics, Symyx and Syrrx.

Crystal Ball: A Look at Future Innovations
MSMitchell Spearrin, Ph.D., Postdoctoral Fellow, Stanford University

Dr. Mitchell Spearrin completed his PhD in Mechanical Engineering in 2014 under Prof. Ronald Hanson. Prior to teaming up with the School of Medicine, Dr. Spearrin’s professional background had primarily been focused on advanced propulsion systems and fundamental combustion studies. As a graduate student, Dr. Spearrin developed novel laser-based gas sensing techniques for measuring flow field properties in harsh combustion environments including shock tubes, supersonic ramjets, and detonation engines. 

KRKate Rosenbluth, Ph.D., CEO, Cala Health

Kate Rosenbluth is the Founding CEO of Cala Health Inc. She received her B.S. from Stanford and a PhD degree in Bioengineering from UCSF and UC Berkeley. She was a postdoctoral engineer in the Department of Neurosurgery at UCSF, a Biodesign Innovation Fellow at Stanford University, and an Innovation Fellow in the Stanford Movement Disorders Laboratory. She has taught entrepreneurship in Stanford Technology Ventures Program, where she recently co-launched a fellowship backed by Accel Ventures.

js

Julie Saiki, SPARK Graduate Student, Stanford University

Julie Saiki completed her M.S. in Medicine from Stanford Medical School and B.A. from Colgate University and is currently doing research in the Mochly-Rosen lab in Stanford’s Chemical and Systems Biology department. As a SPARK scholar, Julie has led the development of an investigational therapeutic from concept to clinical trial. She spent last summer as an MBA intern in Genentech’s strategy and portfolio team where she evaluated development and partnering strategies for a late stage drug candidate. She is also a former Fulbright scholar.

Value-Driven Health Care: What is the Role of Biomedical Innovation?

Dana Goldman, Ph.D. Professor and the Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy and Economics

Dana Goldman is a Professor and the Leonard D. Schaeffer Director’s Chair at the University of Southern California. Until Fall 2009, he held RAND’s Distinguished Chair in Health Economics and directed RAND’s program in Economics, Finance, and Organization. He is also an Adjunct Professor of Health Services and Radiology at UCLA.

ofmanJoshua J. Ofman, M.D., M.S.H.S. (Moderator) SVP, Global Value, Access & Policy, Amgen

Ofman is responsible for directing Amgen activities related to ensuring that Amgen products have a compelling value proposition and obtain market access from payers in each market, worldwide. These activities include global pricing, market access planning, global health economics, international government affairs, and health policy. Prior to joining Amgen in 2003 as head of U.S. Health Economics and Outcomes Research, Ofman was a member of the academic faculty in the Department of Medicine and Health Services Research, UCLA School of Medicine, Cedars-Sinai Medical Center.

lanskyDavid Lansky, Ph.D. President & CEO, Pacific Business Group on Health

David Lansky, PhD, is the President and Chief Executive Officer of the Pacific Business Group on Health (PBGH) and directs its efforts to improve the affordability and availability of high quality health care. Since 2008, David Lansky has led the coalition of 50 large employers and health care purchasers representing over three million Californians, including CalPERS, Wells Fargo, Intel, Safeway, Chevron, and the University of California.

Sandy

 Lewis G. Sandy, M.D., F.A.C.P., Executive Vice President, Clinical Advancement

Lewis G. Sandy, M.D., is senior vice president, Clinical Advancement, UnitedHealth Group. His work focuses on clinical innovation, payment/delivery reforms to modernize the health care system and physician collaboration. He also is a principal in the UnitedHealth Center for Health Reform and Modernization, with a focus on payment/delivery innovation and policy.

Networking Break


HillState Senator Jerry Hill, 13th District

Senator Hill joined the state Legislature’s upper house with a strong track record of leadership and public service as an elected official. He was the mayor of the city of San Mateo, he served on the San Mateo County Board of Supervisors and he was a member of the state Assembly. While on the Board of Supervisors, he was involved in a diverse array of issues from health and safety protections for children, families and seniors, to improvement of schools, the environment roads and public works.

GordonState Assemblymember Rich Gordon, 24th District

Assemblyman Gordon chairs the Assembly Committee on Rules, and is a member of the following Assembly Committees: Business, Professions and Consumer Protection, Budget, Local Government, Revenue & Taxation, and the Budget Subcommittee on Resources and Transportation. He is currently Chair the Select Committee on Sea Level Rise and the California Economy, in addition to chairing the Legislative LGBT Caucus. Additionally, he is Co-Chair of the Bay Area Caucus and is a member of the Environmental Caucus.

The Patient Perspective

MHManny Hernandez, Co-Founder and President, Diabetes Hands Foundation

Manny Hernandez is a Venezuelan-born nonprofit leader, a social media author, and a passionate Hispanic diabetes advocate and key opinion leader who has lived with LADA (Latent Autoimmune Diabetes in Adults) since 2002. In 2007, he started TuDiabetes.org and EsTuDiabetes.org along with his wife, Andreina Davila. In 2008 they co-founded Diabetes Hands Foundation and served as Chairman of the board between 2008 and 2012, growing the board from 5 members to 14, to support the organization’s growth beyond half a million US$ in annual revenue. As President of the Diabetes Hands Foundation, he is responsible for program strategy, fundraising, and partnership development.

The Next Frontier: Life Sciences Convergence with Silicon Valley


MarshallDeborah Marshall (Moderator) Partner, Sidley Austin

Deborah A. Marshall is a partner with the firm and concentrates her practice on strategic business counseling for emerging growth companies and investors at all stages of development, from start-up entrepreneurs to publicly traded entities and technology-based, multinational corporations.

leslie

Leslie Bottorff, Managing Director, Healthcare, GE Ventures

Leslie invests in start-up companies in the healthcare industry, specializing in medical device technology, digital health, and emerging business models. Leslie joined GE Ventures in 2014 after 16 years of experience in venture capital investing as a managing director with ONSET Ventures. Previous investments and board seats include Sadra Medical (sold to Boston Scientific), Spinal Concepts (sold to Abbott Labs), Neuronetics, Relievant, and VisionCare Ophthalmic.

Jason Oberfest, Co-Founder & CEO, Mango Healthoberfest

Jason is an entrepreneur and executive with a track record of delivering new levels of consumer engagement in industries including gaming, social networks, publishing, and e-commerce.Prior to founding Mango Health Jason served as VP, Social Applications at ngmoco, one of the earliest mobile game companies. Jason previously worked as SVP of Business Development and GM of the developer platform at MySpace, as Managing Director of Business Development and Product Management for Los Angeles Times Interactive, and as VP of Strategy at the interactive agency Blast Radius.

googleAfia Asamoah, Product Counsel, Google

Asamoah is a product counsel at Google Inc. Prior to joining Google, Asamoah was regulatory attorney at Covington & Burling LLP, advising pharmaceutical, biotechnology, and medical device clients on a range of FDA-related regulatory and compliance issues. Her work includes internal investigations and audits, legislative activities, interactions with regulatory bodies, and corporate transactions.
Closing Remarks and Reception
RW

Rick Winningham, Chairman & CEO, Theravance Biopharma

Winningham joined Theravance as chief executive officer and member of the board of directors in October 2001, and was appointed chairman of the board in April 2010. Since assuming the role of CEO, Theravance has successfully transitioned from a private research-based small molecule discovery company to a public company with a robust portfolio of product candidates, both in clinical development and on the market. Prior to joining Theravance, Winningham held various management positions with Bristol-Myers Squibb and its predecessor, Bristol-Myers, since 1986. 

 

 

 

RN

CHI Member

Price

Commercial/Service Provider $699
Development-Stage Organizations (Revenue under $25 M) $129
Academic/Non-Profit $129

Non CHI Member

Commercial/Service Provider $899
Development-Stage Organizations (Revenue under $25 M) $199
Academic $199

 

 

Hotel Information:

Rosewood Sand Hill 
2825 Sand Hill Rd
Menlo Park, California
Reservation Line: (650) 561-1515

Room Rate: $415++*
Room Block Deadline: Monday, October 20, 2014
Group Name: CHI – California Healthcare Institute

CHI has booked a room block at The Rosewood Hotel for your convenience. The negotiated room rate is $415++.

Hotel reservations can be made at 1-650-561-1515. Please mention the room block name CHI – California Healthcare Institute to take advantage of the negotiated rate.

The hotel deadline is October 20. As always, room rates are based on availability

Event Information:

Li Ka Shing Center, Second Floor,
Stanford University,
291 Campus Drive West
Palo Alto, CA

Parking Directions

For more information please contact our marketing and events coordinator, Bianca Leveriza, leveriza@chi.org or 858-456-8881.